These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil. JAMA; 1990 Dec; 264(23):2991-2. PubMed ID: 2243420 [No Abstract] [Full Text] [Related]
4. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil]. Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824 [TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Tal A; Rajeshawari M; Isley W South Med J; 1997 May; 90(5):546-7. PubMed ID: 9160078 [TBL] [Abstract][Full Text] [Related]
6. Lovastatin/gemfibrozil myopathy: a clinical, histochemical, and ultrastructural study. Chucrallah A; De Girolami U; Freeman R; Federman M Eur Neurol; 1992; 32(5):293-6. PubMed ID: 1521554 [TBL] [Abstract][Full Text] [Related]
7. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report. Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522 [TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. Landesman KA; Stozek M; Freeman NJ Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341 [TBL] [Abstract][Full Text] [Related]
10. [Myopathy during treatment with fibrates and lovastatin]. Jensen K Ugeskr Laeger; 1991 Mar; 153(12):862. PubMed ID: 2014580 [No Abstract] [Full Text] [Related]
12. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil. Knoll RW; Ciafone R; Galen M Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847 [No Abstract] [Full Text] [Related]
13. Lovastatin and myopathy. Tobert JA Am J Med; 1994 Mar; 96(3):300-1. PubMed ID: 8154521 [No Abstract] [Full Text] [Related]
14. HMG-CoA reductase inhibitors, gemfibrozil, and myopathy. Tobert JA Am J Cardiol; 1995 Apr; 75(12):862. PubMed ID: 7717303 [No Abstract] [Full Text] [Related]
15. Myopathy and rhabdomyolysis with lipid-lowering drugs. Hodel C Toxicol Lett; 2002 Mar; 128(1-3):159-68. PubMed ID: 11869826 [TBL] [Abstract][Full Text] [Related]
16. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. Kind AH; Zakowski LJ; McBride PE WMJ; 2002; 101(7):53-6. PubMed ID: 12426921 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias. Glueck CJ; Speirs J; Tracy T J Lab Clin Med; 1990 May; 115(5):603-9. PubMed ID: 2341762 [TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Marais GE; Larson KK Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197 [No Abstract] [Full Text] [Related]
19. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM Arch Intern Med; 1994 Jan; 154(1):73-82. PubMed ID: 8267492 [TBL] [Abstract][Full Text] [Related]